University of California San Diego

$1M Gift Speeds COVID-19 Testing and Tracking at UC San Diego

Funds from the John and Mary Tu Foundation support the work of translational research virologist Davey Smith, M.D.
1-Jun-2020 4:15 PM EDT, by University of California San Diego

Newswise — A $1 million gift from the John and Mary Tu Foundation is helping to increase the number of people tested for COVID-19, as well as develop new ways to track and treat the virus. The award supports the clinical research activities of University of California San Diego translational research virologist Davey Smith, M.D., M.A.S., who is advancing new diagnostics, therapies and ways to monitor the spread of the virus.

“What we are trying to do is save lives,” said John Tu regarding the creation of the John and Mary Tu Foundation COVID-19 Response Fund. “It’s very simple: with this research, Dr. Smith is working on behalf of everybody, to save us, to save the world.”

“At this critical time during the COVID-19 pandemic, the generosity of the John and Mary Tu Foundation has an immediate positive impact on our efforts,” said Chancellor Pradeep K. Khosla. “Their support allows experts like Davey Smith to quickly mobilize to mitigate the spread of the virus and develop treatments for those affected.”

At the onset of the pandemic, Smith and his team immediately began to investigate methods that would increase the efficiency of testing as well as understand the disease process—how does the virus mutate and spread within a population? Through sequencing the virus, he is able to track the disease as it spreads into vulnerable populations, which informs the best means for contact tracing (a process of supporting patients and warning contacts of exposure in order to stop chains of transmission). Smith is also leading clinical trials to test new drugs for treatment of COVID-19 for those who have moderately severe cases.

According to Smith, prior to this gift, he and his team had limited resources, which would have frozen their progress.  “Without the support of the John and Mary Tu Foundation, we would not have been able to continue in our CoV-2 lab-based and clinical research,” he explained. “The foundation saw that time was of the essence in this pandemic and that science was going to get us out of it. Now we are conducting a number of clinical trials, including those for vaccines, and have found new drugs that will likely move to treatments soon.”

As chief of UC San Diego’s Division of Infectious Diseases and Global Public Health and co-director of the San Diego Center for AIDS Research, Smith and his team are uniquely positioned to rapidly respond to the spread of COVID-19, as well as forecast the pandemic. “It’s not a matter of if a pandemic can happen, but when,” said Smith. “We need to bolster science, technology and capabilities to prepare for pandemics.”

Smith has been on the front lines as the virus evolves. He has leveraged core technologies and partnered with top clinical infectious disease specialists at UC San Diego to conduct diagnostic tests, identify and test new antiviral drugs, develop antibody therapies, and launch vaccine trials. Now, thanks to the new gift, he has the resources needed to speed COVID-19 discoveries, minimize exposure and save lives.

The gift from the John and Mary Tu Foundation strengthens UC San Diego’s efforts to respond to the pandemic. The university launched a COVID-19 Emergency Response Fund to address the greatest needs in this evolving situation, and move forward with research and health care efforts to better understand and respond to COVID-19. Learn more about the COVID-19 Emergency Response Fund and how your philanthropy – as part of the Campaign for UC San Diego – can help develop new treatments for those affected by the disease.  

Together, we are continuing our nontraditional path toward revolutionary ideas, unexpected answers, lifesaving discoveries and planet-changing impact. To learn more about the Campaign for UC San Diego, a university-wide comprehensive fundraising effort concluding in 2022, visit

Filters close

Showing results

110 of 2529
Newswise: Drug that calms ‘cytokine storm’ associated with 45% lower risk of dying among COVID-19 patients on ventilators
Released: 13-Jul-2020 7:25 AM EDT
Drug that calms ‘cytokine storm’ associated with 45% lower risk of dying among COVID-19 patients on ventilators
Michigan Medicine - University of Michigan

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn’t receive the drug, according to a new observational study.

10-Jul-2020 9:00 AM EDT
Long-term strategies to control COVID-19 pandemic must treat health and economy as equally important, argue researchers
University of Cambridge

Strategies for the safe reopening of low and middle-income countries (LMICs) from months of strict social distancing in response to the ongoing COVID-19 pandemic must recognise that preserving people’s health is as important as reviving the economy, argue an international team of researchers.

Released: 10-Jul-2020 3:05 PM EDT
Simple blood test can predict severity of COVID-19 for some patients
University of Texas Health Science Center at Houston

An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of Laboratory Hematology.

Released: 10-Jul-2020 12:50 PM EDT
Genetic ‘fingerprints’ of first COVID-19 cases help manage pandemic
University of Sydney

A new study published in the world-leading journal Nature Medicine, reveals how genomic sequencing and mathematical modelling gave important insights into the ‘parentage’ of cases and likely spread of the disease in New South Wales.

Released: 10-Jul-2020 12:35 PM EDT
Our itch to share helps spread COVID-19 misinformation
Massachusetts Institute of Technology (MIT)

To stay current about the Covid-19 pandemic, people need to process health information when they read the news. Inevitably, that means people will be exposed to health misinformation, too, in the form of false content, often found online, about the illness.

Newswise: Pandemic Inspires Framework for Enhanced Care in Nursing Homes
Released: 10-Jul-2020 12:25 PM EDT
Pandemic Inspires Framework for Enhanced Care in Nursing Homes
University of Pennsylvania School of Nursing

As of May 2020, nursing home residents account for a staggering one-third of the more than 80,000 deaths due to COVID-19 in the U.S. This pandemic has resulted in unprecedented threats—like reduced access to resources needed to contain and eliminate the spread of the virus—to achieving and sustaining care quality even in the best nursing homes. Active engagement of nursing home leaders in developing solutions responsive to the unprecedented threats to quality standards of care delivery is required.

Newswise: General Electric Healthcare Chooses UH to Clinically 
Evaluate First-of-its-kind Imaging System
Released: 10-Jul-2020 12:15 PM EDT
General Electric Healthcare Chooses UH to Clinically Evaluate First-of-its-kind Imaging System
University Hospitals Cleveland Medical Center

University Hospitals Cleveland Medical Center physicians completed evaluation for the GE Healthcare Critical Care Suite, and the technology is now in daily clinical practice – flagging between seven to 15 collapsed lungs per day within the hospital. No one on the team could have predicted the onset of the COVID-19 pandemic, but this technology and future research with GEHC may enhance the capability to improve care for COVID-19 patients in the ICU. Critical Care Suite is now assisting in COVID and non-COVID patient care as the AMX 240 travels to intensive care units within the hospital.

Released: 10-Jul-2020 11:50 AM EDT
COVID-19 Can Be Transmitted in the Womb, Reports Pediatric Infectious Disease Journal
Wolters Kluwer Health: Lippincott Williams and Wilkins

A baby girl in Texas – born prematurely to a mother with COVID-19 – is the strongest evidence to date that intrauterine (in the womb) transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Released: 10-Jul-2020 9:45 AM EDT
How COVID-19 Shifted Inpatient Imaging Utilization
Harvey L. Neiman Health Policy Institute

As medical resources shifted away from elective and non-urgent procedures toward emergent and critical care of COVID-19 patients, departments were forced to reconfigure their personnel and resources. In particular, many Radiology practices rescheduled non-urgent and routine imaging according to recommendations from the American College of Radiology (ACR). This new Harvey L. Neiman Health Policy Institute study, published online in the Journal of American College of Radiology (JACR), evaluates the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic within a large healthcare system.

Showing results

110 of 2529